Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-25 @ 2:07 AM
NCT ID:
NCT06062160
Eligibility Criteria:
Inclusion Criteria:
* • Those between the ages of 18 and 45
* Multiparous women
* At the 8th postoperative hour
* Women who have not developed any complications during pregnancy, birth and postpartum for themselves or their newborns.
* Having a single, healthy newborn at term,
* Does not react negatively to any attempt to touch,
* Able to speak and communicate in Turkish
* Agreeing to participate in the study
Exclusion Criteria:
* Those with any problems diagnosed before or at birth (such as oligohydramnios, preeclampsia, heart disease, diabetes, placenta previa)
* Those who develop any complications related to mother and baby in the postpartum period (bleeding, hypertension, babies taken to the neonatal intensive care unit, etc.).
* Those who receive different analgesics other than routine post-operative analgesics (75 mg diclofenac sodium in the first 30 minutes post-op).
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT06062160
Study Brief:
Protocol Section:
NCT06062160